The Clinical Need for Corventis Avivo
Corventis’ Avivo offering marks a significant advance in terms of patient convenience and compliance. We are about to launch the Avivo patient management system for congestive heart failure. The number one cause for readmission post discharge is fluid accumulation in the chest because the pumping system in the heart isn’t strong enough to get the fluid out of the system.
Silicon Valley heard about this and decided that it sounded likes a problem it should solve. DARPA actually paid some of these people to figure out the problem of dehydration for soldiers in the field — and they decided if they could measure dehydration with a wearable sensor platform, why not measure hydration problems, too? Fluid accumulation is in essence a hydration problem. We are essentially replacing the weight scale which is a systemic measure of weight change. By the time you have enough weight increase that it can be picked up via the sensitivity of the weight scale, you typically need to go right to the hospital. With this system, we can detect fluid accumulation locally, rather than systemically. What we are able to do is detect 14 days prior to when symptoms are generally detected, we can enable a physician to order oral diuretics to prevent rehospitalization, which is an enormous cost saver for the system.
Here’s Goldberg’s full presentation (PDF)
Navigation: ( ←Previous | 1 2 3 4 5 6 | Next→ )